BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30980593)

  • 1. Structural analyses reveal that MBD3 is a methylated CG binder.
    Liu K; Lei M; Wu Z; Gan B; Cheng H; Li Y; Min J
    FEBS J; 2019 Aug; 286(16):3240-3254. PubMed ID: 30980593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain.
    Lei M; Tempel W; Chen S; Liu K; Min J
    Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194409. PubMed ID: 31356990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA.
    Cramer JM; Scarsdale JN; Walavalkar NM; Buchwald WA; Ginder GD; Williams DC
    J Biol Chem; 2014 Jan; 289(3):1294-302. PubMed ID: 24307175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
    Jiang CL; Jin SG; Pfeifer GP
    J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Densely methylated DNA traps Methyl-CpG-binding domain protein 2 but permits free diffusion by Methyl-CpG-binding domain protein 3.
    Leighton GO; Irvin EM; Kaur P; Liu M; You C; Bhattaram D; Piehler J; Riehn R; Wang H; Pan H; Williams DC
    J Biol Chem; 2022 Oct; 298(10):102428. PubMed ID: 36037972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells.
    Hainer SJ; McCannell KN; Yu J; Ee LS; Zhu LJ; Rando OJ; Fazzio TG
    Elife; 2016 Nov; 5():. PubMed ID: 27849519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.
    Pan H; Bilinovich SM; Kaur P; Riehn R; Wang H; Williams DC
    Nucleic Acids Res; 2017 Sep; 45(15):9164-9177. PubMed ID: 28637186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of paternal methylation and repression of the imprinted H19 gene requires MBD3.
    Reese KJ; Lin S; Verona RI; Schultz RM; Bartolomei MS
    PLoS Genet; 2007 Aug; 3(8):e137. PubMed ID: 17708683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.
    Saito M; Ishikawa F
    J Biol Chem; 2002 Sep; 277(38):35434-9. PubMed ID: 12124384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences.
    Günther K; Rust M; Leers J; Boettger T; Scharfe M; Jarek M; Bartkuhn M; Renkawitz R
    Nucleic Acids Res; 2013 Mar; 41(5):3010-21. PubMed ID: 23361464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-CpG-binding domain proteins: readers of the epigenome.
    Du Q; Luu PL; Stirzaker C; Clark SJ
    Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.
    Le Guezennec X; Vermeulen M; Brinkman AB; Hoeijmakers WA; Cohen A; Lasonder E; Stunnenberg HG
    Mol Cell Biol; 2006 Feb; 26(3):843-51. PubMed ID: 16428440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66α).
    Walavalkar NM; Gordon N; Williams DC
    J Biol Chem; 2013 Feb; 288(5):3419-27. PubMed ID: 23239876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the roles of MBD2 isoforms and domains in regulating NuRD complex function during cellular differentiation.
    Schmolka N; Karemaker ID; Cardoso da Silva R; Recchia DC; Spegg V; Bhaskaran J; Teske M; de Wagenaar NP; Altmeyer M; Baubec T
    Nat Commun; 2023 Jun; 14(1):3848. PubMed ID: 37385984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family-wide Characterization of Methylated DNA Binding Ability of Arabidopsis MBDs.
    Wu Z; Chen S; Zhou M; Jia L; Li Z; Zhang X; Min J; Liu K
    J Mol Biol; 2022 Jan; 434(2):167404. PubMed ID: 34919920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
    Zhang Y; Ng HH; Erdjument-Bromage H; Tempst P; Bird A; Reinberg D
    Genes Dev; 1999 Aug; 13(15):1924-35. PubMed ID: 10444591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.